Ridgecrest Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Sell |
4,304
-300
| -7% | -$33.3K | 0.25% | 63 |
|
|
2025
Q1 | $516K | Sell |
4,604
-14
| -0.3% | -$1.57K | 0.27% | 60 |
|
|
2024
Q4 | $427K | Buy |
4,618
+12
| +0.3% | +$1.11K | 0.23% | 65 |
|
|
2024
Q3 | $386K | Buy |
4,606
+150
| +3% | +$12.6K | 0.2% | 75 |
|
|
2024
Q2 | $306K | Hold |
4,456
| – | – | 0.18% | 81 |
|
|
2024
Q1 | $326K | Hold |
4,456
| – | – | 0.19% | 78 |
|
|
2023
Q4 | $361K | Sell |
4,456
-637
| -13% | -$51.6K | 0.24% | 69 |
|
|
2023
Q3 | $382K | Hold |
5,093
| – | – | 0.27% | 61 |
|
|
2023
Q2 | $393K | Buy |
5,093
+302
| +6% | +$23.3K | 0.26% | 63 |
|
|
2023
Q1 | $398K | Hold |
4,791
| – | – | 0.28% | 59 |
|
|
2022
Q4 | $411K | Hold |
4,791
| – | – | 0.31% | 57 |
|
|
2022
Q3 | $296K | Sell |
4,791
-440
| -8% | -$27.2K | 0.24% | 72 |
|
|
2022
Q2 | $323K | Sell |
5,231
-250
| -5% | -$15.4K | 0.24% | 75 |
|
|
2022
Q1 | $326K | Sell |
5,481
-1,000
| -15% | -$59.5K | 0.21% | 85 |
|
|
2021
Q4 | $471K | Sell |
6,481
-174
| -3% | -$12.6K | 0.23% | 76 |
|
|
2021
Q3 | $465K | Buy |
6,655
+100
| +2% | +$6.99K | 0.25% | 72 |
|
|
2021
Q2 | $451K | Buy |
6,555
+300
| +5% | +$20.6K | 0.28% | 67 |
|
|
2021
Q1 | $404K | Buy |
+6,255
| New | +$404K | 0.39% | 55 |
|